Equity Research Analysts at B.Riley FBR Kept the Same their Buy rating for Lincoln Electric Holdings (LECO). The Price Objective is $115.0; 12 Analysts Covering Agios Pharmaceuticals, Inc. (AGIO)

February 15, 2018 - By Dolores Ford

Among 13 analysts covering Lincoln Electric (NASDAQ:LECO), 6 have Buy rating, 0 Sell and 7 Hold. Therefore 46% are positive. Lincoln Electric has $105.0 highest and $51 lowest target. $94.29’s average target is 4.18% above currents $90.51 stock price. Lincoln Electric had 42 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Monday, August 21 by FBR Capital. On Wednesday, July 26 the stock rating was maintained by RBC Capital Markets with “Hold”. The firm earned “Market Perform” rating on Thursday, April 14 by William Blair. RBC Capital Markets maintained the shares of LECO in report on Tuesday, July 28 with “Sector Perform” rating. The stock has “Equal-Weight” rating by Barclays Capital on Wednesday, January 24. RBC Capital Markets maintained the stock with “Hold” rating in Thursday, January 11 report. The firm earned “Buy” rating on Tuesday, January 16 by Stifel Nicolaus. The stock of Lincoln Electric Holdings, Inc. (NASDAQ:LECO) earned “Neutral” rating by Longbow on Wednesday, February 15. Stifel Nicolaus maintained Lincoln Electric Holdings, Inc. (NASDAQ:LECO) on Friday, July 14 with “Hold” rating. Oppenheimer initiated Lincoln Electric Holdings, Inc. (NASDAQ:LECO) on Wednesday, April 27 with “Market Perform” rating.

Among 16 analysts covering Agios Pharmaceuticals (NASDAQ:AGIO), 12 have Buy rating, 0 Sell and 4 Hold. Therefore 75% are positive. Agios Pharmaceuticals had 41 analyst reports since July 23, 2015 according to SRatingsIntel. On Tuesday, August 8 the stock rating was maintained by Oppenheimer with “Buy”. RBC Capital Markets maintained the shares of AGIO in report on Wednesday, November 1 with “Buy” rating. The firm has “Outperform” rating by Northland Capital given on Thursday, July 23. The firm has “Buy” rating given on Tuesday, October 3 by SunTrust. As per Friday, August 7, the company rating was maintained by Canaccord Genuity. The rating was maintained by J.P. Morgan with “Buy” on Monday, September 18. The firm has “Overweight” rating by JP Morgan given on Monday, June 13. The company was maintained on Tuesday, August 1 by Cowen & Co. The stock of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) earned “Buy” rating by Oppenheimer on Tuesday, August 1. Leerink Swann upgraded the stock to “Outperform” rating in Wednesday, August 2 report. See Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) latest ratings:

19/11/2017 Broker: SunTrust Rating: Buy New Target: $80.0 Maintain
01/11/2017 Broker: RBC Capital Markets Rating: Buy New Target: $80.0 Maintain
02/11/2017 Broker: Credit Suisse Rating: Outperform Old Target: $61 New Target: $66 Maintain
03/10/2017 Broker: SunTrust Rating: Buy New Target: $80.0 Maintain
18/09/2017 Broker: J.P. Morgan Rating: Buy New Target: $76.0 Maintain
15/09/2017 Broker: Needham Rating: Buy New Target: $72.0 Maintain
15/09/2017 Broker: RBC Capital Markets Rating: Outperform New Target: $78 Initiates Coverage On

The stock increased 1.61% or $1.43 during the last trading session, reaching $90.51. About 1.18 million shares traded or 179.15% up from the average. Lincoln Electric Holdings, Inc. (NASDAQ:LECO) has risen 53.15% since February 15, 2017 and is uptrending. It has outperformed by 36.45% the S&P500.

Since September 11, 2017, it had 0 insider purchases, and 1 sale for $272,726 activity. Another trade for 3,080 shares valued at $272,726 was sold by Kuhrt Michele R.

Lincoln Electric Holdings, Inc., through its subsidiaries, designs, makes, and sells welding, cutting, and brazing products worldwide. The company has market cap of $5.95 billion. It operates through three divisions: Americas Welding, International Welding, and The Harris Products Group. It has a 21.79 P/E ratio. The company??s welding products include arc welding power sources, plasma cutters, wire feeding systems, robotic welding packages, integrated automation systems, fume extraction equipment, consumable electrodes, fluxes and welding accessories, and specialty welding consumables and fabrication products.

Investors sentiment increased to 1.56 in Q3 2017. Its up 0.08, from 1.48 in 2017Q2. It increased, as 27 investors sold Lincoln Electric Holdings, Inc. shares while 68 reduced holdings. 42 funds opened positions while 106 raised stakes. 41.08 million shares or 3.50% less from 42.57 million shares in 2017Q2 were reported. Fayez Sarofim accumulated 255,700 shares or 0.12% of the stock. Greenleaf reported 0.01% of its portfolio in Lincoln Electric Holdings, Inc. (NASDAQ:LECO). Us Bank De reported 19,521 shares stake. Hanseatic Mngmt Services Incorporated holds 0.57% of its portfolio in Lincoln Electric Holdings, Inc. (NASDAQ:LECO) for 5,438 shares. Moors And Cabot Inc holds 0.06% or 4,900 shares. Fdx Advsrs holds 3,345 shares or 0.01% of its portfolio. Ls Investment Ltd Co has invested 0.03% in Lincoln Electric Holdings, Inc. (NASDAQ:LECO). Bradley Foster And Sargent Ct holds 0.02% or 6,880 shares. Jfs Wealth Advisors Limited reported 147 shares or 0% of all its holdings. Sequoia Limited Liability Com invested 0.13% in Lincoln Electric Holdings, Inc. (NASDAQ:LECO). Nationwide Fund Advsrs stated it has 133,596 shares. Penobscot Invest invested in 0.08% or 3,000 shares. Fisher Asset Management Limited Co has 0.14% invested in Lincoln Electric Holdings, Inc. (NASDAQ:LECO). Moreover, National Bank Of Mellon Corporation has 0.02% invested in Lincoln Electric Holdings, Inc. (NASDAQ:LECO). Alps Advisors Incorporated holds 0% in Lincoln Electric Holdings, Inc. (NASDAQ:LECO) or 5,267 shares.

The stock increased 1.88% or $1.44 during the last trading session, reaching $77.97. About 1.08M shares traded or 86.65% up from the average. Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) has risen 8.52% since February 15, 2017 and is uptrending. It has underperformed by 8.18% the S&P500.

Since August 22, 2017, it had 0 buys, and 22 selling transactions for $25.02 million activity. $5.61M worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) shares were sold by Schenkein David P. Another trade for 4,000 shares valued at $284,380 was sold by Cantley Lewis Clayton Jr.. On Monday, October 2 Biller Scott sold $144,276 worth of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) or 2,146 shares. Shares for $161,250 were sold by Alenson Carman. Shares for $157,500 were sold by Bowden Christopher. $1.87 million worth of stock was sold by Hoerter Steven L. on Tuesday, January 23.

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>